Optovue

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Optovue sits in the top decile of US sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count).

12 total trials none currently recruiting 12 completed top decile by trial count

Optovue: 12 sponsored US clinical trials, none currently recruiting.

Optovue sponsors 12 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 12 completed. The most-studied condition in this pipeline is Cornea Pathology, with 1 trials.

Top-decile sponsor footprint

Optovue ranks in the top decile of sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

12 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

12 total, page 1 of 1

COMPLETED

Performance Evaluation of OCT and OCT Angiography-based Ocular Measurements (Optical Coherence Tomography)

NCT04437082
COMPLETED

Data Collection of OCT and OCTA-based Ocular Measurements

NCT03887104
COMPLETED

Precision of OCT and OCTA-based Ocular Measurements

NCT03859310
COMPLETED

Comparison of OCT and OCTA-based Ocular Measurements to Those of Predicate

NCT03852485
COMPLETED

Evaluation of the Repeatability and Reproducibility of Corneal Epithelial Thickness Mapping With SD-OCT

NCT02600546
COMPLETED

Evaluation of OCT Measurements

NCT01806402
COMPLETED

Evaluation of Corneal Epithelial Thickness Mapping

NCT01712022
COMPLETED

iCam Clinical Validation Study

NCT01600261
COMPLETED

Optical Coherence Tomography (OCT) Data Collection Study

NCT01459731
COMPLETED

Clinical Validation Study of RTVue Features

NCT01370850
COMPLETED

Clinical Validation Study for iVue

NCT01242553
COMPLETED

Evaluation of RTVue in Corneal Measurement

NCT01220193

Therapeutic Areas

Cornea Pathology 1
Post Laser Refractive Surgery 1
Normal Cornea 1
Repeatability & Reproducibility 1
Cataract Surgery 1

How the Optovue archive is shaped

12 indexed studies, none listed as recruiting (0% open); 12 completed (100%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Cornea Pathology (1 trial), 4 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Optovue: archived-pipeline peers nationwide

Peers matched on 12 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Optovue sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%5%10%15%20% Total trials Recruiting share OptovueAlachua Government ServicesAllergy TherapeuticsAmpio Pharmaceuticals.Angiodynamics10xBio22nd Century Group23andMe3-C Institute for Social Development
Optovue sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Optovue sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 12 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Optovue page

12 registered trials is a research-attention snapshot, not an endorsement of Optovue or any single study.

  • None of Optovue's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Cornea Pathology is the condition Optovue studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cornea Pathology trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Optovue pipeline card: 12 registered trials from official public datasets.Report a data error.